Experience
Shire ViroPharma Inc.
CSL Behring LLC
Represented defendant CSL Behring in patent litigation concerning its biologic Haegarda® for the prophylactic prevention of hereditary angioedema.
Shire ViroPharma Inc. v. CSL Behring LLC, 1:17-cv-00414, D. Del., Judges Goldberg, Thynge
CSL Behring GmbH v. Shire ViroPharma Inc.
CSL Behring GmbH
KeyMe, LLC v. The Hillman Group, Inc.
The Hillman Group, Inc.
Novartis Vaccines & Diagnostics, Inc. v. MedImmune, LLC
MedImmune, LLC
Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.
Biogen International GmbH
Biogen Int’l GmbH v. Amneal Pharmaceuticals LLC et al.
Biogen Int’l GmbH
Bonutti Skeletal Innovations, LLC v. ConforMIS, Inc.
ConforMIS, Inc.
Parallel Networks, LLC v. SAP America, Inc.
SAP America, Inc.
CardioNet LLC et al. v. InfoBionic, Inc.
CardioNet LLC et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.